Home › Funds › Omega Fund Management, LLC › BBNX
Omega Fund Management, LLC position in BBNX
BETA BIONICS INC · Health Care
Omega Fund Management, LLC reported holding 962,010 shares of BBNX (BETA BIONICS INC) in its Q3 2026 13F filing — a position valued at US$18.3M, representing 14.59% of its reported portfolio and ranking #3 among its reported holdings. Omega Fund Management, LLC has disclosed BBNX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Omega Fund Management, LLC's BBNX position evolved
Omega Fund Management, LLC first disclosed a stake in BBNX in Q1 2025 at 1,988,287 shares (US$24.3M). The position peaked in Q4 2025 at 1,316,183 shares, worth US$40.1M. Across 7 filings, Omega Fund Management, LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 962,010 shares valued at US$18.3M — a reduction of -354,173 shares quarter over quarter.. Notable position changes include a 31% trim in Q4 2025 (shares fell 67% over the following quarter), a 27% trim in Q3 2026 (shares fell 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 1.99M | $24.34M | New |
| Q2 2025 | 1.99M | $28.95M | Hold |
| Q3 2025 | 1.92M | $38.15M | Reduce |
| Q4 2025 | 1.32M | $40.10M | Reduce |
| Q1 2026 | 1.32M | $13.19M | Hold |
| Q2 2026 | 1.32M | $20.62M | Hold |
| Q3 2026 | 962.01K | $18.26M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BBNX and 13F data
BBNX (BETA BIONICS INC) is a Health Care company. 55 other funds we track also report a position in BBNX — the largest reported positions include EVENTIDE ASSET MANAGEMENT, LLC (US$133.7M), Sands Capital Alternatives, LLC (US$75.9M), Soleus Capital Management, L.P. (US$68.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BBNX
- EVENTIDE ASSET MANAGEMENT, LLC 7.04M sh · $133.72M · Q3 2026
- Sands Capital Alternatives, LLC 4.00M sh · $75.88M · Q3 2026
- Soleus Capital Management, L.P. 4.39M sh · $68.85M · Q2 2026
- Vestal Point Capital, LP 1.60M sh · $25.07M · Q2 2026
- Eversept Partners, LP 1.02M sh · $19.43M · Q3 2026
- Divisadero Street Capital Management, LP 1.11M sh · $17.45M · Q2 2026
- Bruce & Co., Inc. 665.70K sh · $12.63M · Q3 2026
- PURA VIDA INVESTMENTS, LLC 281.16K sh · $4.41M · Q2 2026
- Archon Capital Management LLC 83.87K sh · $1.59M · Q3 2026
More on Omega Fund Management, LLC
FAQ
How long has Omega Fund Management, LLC held BBNX?
Omega Fund Management, LLC has disclosed BBNX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Omega Fund Management, LLC's current position in BBNX?
As of Q3 2026, Omega Fund Management, LLC holds 962.01K shares of BBNX (BETA BIONICS INC), valued at $18.26M, representing 14.59% of its reported portfolio and ranking #3.
Has Omega Fund Management, LLC been buying or selling BBNX?
In the latest 13F filing (Q3 2026), Omega Fund Management, LLC reduced its position in BBNX. The position peaked in Q4 2025 at 1.32M shares.
Which other funds hold BBNX?
Other major institutional holders of BBNX include EVENTIDE ASSET MANAGEMENT, LLC, Sands Capital Alternatives, LLC, Soleus Capital Management, L.P., among 55 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.